BridgeBio Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$4.39 | $0.16 | -$0.74 |
| Q2 2024 | 2 | -$5.95 | $0.21 | -$1.00 |
| Q3 2024 | 1 | -$5.98 | $0.22 | -$1.00 |
| Q4 2024 | 4 | -$1.31 | -$0.93 | -$1.10 |
| Q1 2025 | 3 | -$1.18 | -$0.82 | -$0.95 |
| Q2 2025 | 1 | -$5.73 | $0.21 | -$0.96 |
| Q3 2025 | 1 | -$5.72 | $0.21 | -$0.96 |
| Q4 2025 | 1 | -$5.20 | $0.19 | -$0.87 |
| Q1 2026 | 1 | -$5.78 | $0.21 | -$0.97 |
| Q2 2026 | 1 | -$3.87 | $0.14 | -$0.65 |
| Q3 2026 | 1 | -$4.83 | $0.17 | -$0.81 |
| Q4 2026 | 1 | -$4.53 | $0.16 | -$0.76 |
BridgeBio Pharma, Inc. Earnings Date And Information
BridgeBio Pharma, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.86 earnings per share for the quarter, topping analysts' consensus estimates of $-1.03 by $0.17. The company had revenue of 2.73 M for the quarter and had revenue of 9.30 M for the year. BridgeBio Pharma, Inc. has generated $-4 earnings per share over the last year ($-3.95 diluted earnings per share) and currently has a price-to-earnings ratio of -9.6. BridgeBio Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
BridgeBio Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.86 | $1.68 M | $2.73 M | ||
| 08/01/2024 | Q2 2024 | -$1.09 | -$0.39 | 0.7 | $3.96 M | $2.17 M |
| 05/02/2024 | Q1 2024 | -$0.40 | -$0.20 | 0.2 | $211.12 M | |
| 02/22/2024 | Q4 2023 | -$0.95 | -$0.96 | -0.01 | $1.75 M | |
| 11/02/2023 | Q3 2023 | -$0.86 | -$1.08 | -0.22 | $3.62 M | $4.09 M |
| 08/03/2023 | Q2 2023 | -$0.86 | -$0.98 | -0.12 | $2.99 M | $1.64 M |
| 05/04/2023 | Q1 2023 | -$0.84 | -$1.16 | -0.32 | $1.83 M | |
| 02/23/2023 | Q4 2022 | -$0.86 | -$1.04 | -0.18 | $1.87 M | |
| 11/03/2022 | Q3 2022 | -$1.02 | -$1.00 | 0.02 | $4.09 M | $338,000 |
| 08/04/2022 | Q2 2022 | -$0.92 | $0.40 | 1.32 | $27.19 M | $73.75 M |
| 05/05/2022 | Q1 2022 | -$1.13 | -$1.69 | -0.56 | $1.69 M | |
| 02/25/2022 | Q4 2021 | -$1.01 | $12.89 M | |||
| 11/04/2021 | Q3 2021 | -$0.91 | -$1.06 | -0.15 | $15.80 M | $2.34 M |
| 08/05/2021 | Q2 2021 | -$0.93 | -$0.66 | 0.27 | $28.49 M | $54.02 M |
| 05/06/2021 | Q1 2021 | -$0.87 | -$1.18 | -0.31 | $462,000 | |
| 02/25/2021 | Q4 2020 | -$0.86 | -$1.01 | -0.15 | $122,000 | |
| 11/05/2020 | Q3 2020 | -$0.97 | -$0.98 | -0.01 | $10.75 M | $8.13 M |
| 08/11/2020 | Q2 2020 | -$0.79 | -$1.03 | -0.24 | $0 | |
| 05/13/2020 | Q1 2020 | -$0.78 | $0 | |||
| 03/03/2020 | Q4 2019 | -$0.62 | $13.82 M |
BridgeBio Pharma, Inc. Earnings: Frequently Asked Questions
-
When is BridgeBio Pharma, Inc.'s earnings date?
BridgeBio Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did BridgeBio Pharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, BridgeBio Pharma, Inc. (:BBIO) reported $-0.86 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.03 by $0.17.
-
How can I listen to BridgeBio Pharma, Inc.'s earnings conference call?
The conference call for BridgeBio Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read BridgeBio Pharma, Inc.'s conference call transcript?
The conference call transcript for BridgeBio Pharma, Inc.'s latest earnings report can be read online.
-
How much revenue does BridgeBio Pharma, Inc. generate each year?
BridgeBio Pharma, Inc. (:BBIO) has a recorded annual revenue of $9.30 M.
-
How much profit does BridgeBio Pharma, Inc. generate each year?
BridgeBio Pharma, Inc. (:BBIO) has a recorded net income of $9.30 M. BridgeBio Pharma, Inc. has generated $-3.95 earnings per share over the last four quarters.
-
What is BridgeBio Pharma, Inc.'s price-to-earnings ratio?
BridgeBio Pharma, Inc. (:BBIO) has a price-to-earnings ratio of -9.6 and price/earnings-to-growth ratio is -1.15.
